From October 1, 2022 to December 31, 2022, the company has repurchased 1,303,600 shares, representing 0.12% for CNY 18.43 million. With this, the company has completed the repurchase of 11,937,264 shares, representing 1.04% for CNY 170.04 million under the buyback announced on May 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.14 CNY | +0.31% | -3.60% | -13.21% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.21% | 2.17B | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+17.90% | 228B | |
+14.86% | 177B | |
+0.45% | 164B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.